日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Belzutifan for Renal Cell Carcinoma in von Hippel-Lindau Disease

Belzutifan 用于治疗伴有 von Hippel-Lindau 病的肾细胞癌

Jonasch, Eric; Donskov, Frede; Iliopoulos, Othon; Rathmell, W Kimryn; Narayan, Vivek K; Maughan, Benjamin L; Oudard, Stephane; Else, Tobias; Maranchie, Jodi K; Welsh, Sarah J; Thamake, Sanjay; Park, Eric K; Perini, Rodolfo F; Linehan, W Marston; Srinivasan, Ramaprasad

Inhibition of hypoxia-inducible factor-2α in renal cell carcinoma with belzutifan: a phase 1 trial and biomarker analysis

贝祖替凡抑制肾细胞癌中缺氧诱导因子-2α:一项I期临床试验和生物标志物分析

Choueiri, Toni K; Bauer, Todd M; Papadopoulos, Kyriakos P; Plimack, Elizabeth R; Merchan, Jaime R; McDermott, David F; Michaelson, M Dror; Appleman, Leonard J; Thamake, Sanjay; Perini, Rodolfo F; Zojwalla, Naseem J; Jonasch, Eric

Radiosynthesis of clinical doses of ⁶⁸Ga-DOTATATE (GalioMedix™) and validation of organic-matrix-based ⁶⁸Ge/⁶⁸Ga generators

⁶⁸Ga-DOTATATE(GalioMedix™)临床剂量的放射合成和基于有机基质的⁶⁸Ge/⁶⁸Ga 发生器的验证

Izabela Tworowska, David Ranganathan, Sanjay Thamake, Ebrahim Delpassand, Alireza Mojtahedi, Michael K Schultz, Konstantin Zhernosekov, Sebastian Marx

Reciprocal regulation of annexin A2 and EGFR with Her-2 in Her-2 negative and herceptin-resistant breast cancer

膜联蛋白 A2 和 EGFR 与 Her-2 在 Her-2 阴性和赫赛汀耐药乳腺癌中的相互调节

Praveenkumar K Shetty, Sanjay I Thamake, Swati Biswas, Sonny L Johansson, Jamboor K Vishwanatha

A competitive hexapeptide inhibitor of annexin A2 prevents hypoxia-induced angiogenic events

膜联蛋白A2的竞争性六肽抑制剂可阻止缺氧诱导的血管生成事件

Valapala, Mallika; Thamake, Sanjay I; Vishwanatha, Jamboor K